Auxly Cannabis Group Inc.
TSX:XLY.TODrug Manufacturers - Specialty & Generic
+$0.00 today
- Market cap
- $364.42M
- Beta
- 1.16
- P/E (TTM)
- 7.3
- EPS (TTM)
- $0.02
Volume 0.13M
Average 0.71M
XLY.TO Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Auxly Cannabis Group Inc.TSX: XLY.TO
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows in line with its trailing trend
Q1 FY2026 depreciation & amortization of CA$2.99M rose 16.2% year over year, ahead of the +14.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at -17.2% a year.
Context
- Depreciation & amortization amounted to 7.6% of revenue in FY2025, down 0.8 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +16.2% holds above the trailing-twelve-month pace of +14.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
CAD · from the income statement
- Latest · FY2025
- 11.45M CAD
- Year-over-year change
- +11.4%
- 4-year CAGR
- -5.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.45M | +11.4% |
| FY2024 | 2024-12-31 | 10.28M | -8.3% |
| FY2023 | 2023-12-31 | 11.21M | -44.5% |
| FY2022 | 2022-12-31 | 20.18M | +41.4% |
| FY2021 | 2021-12-31 | 14.27M | — |
Depreciation & Amortization vs competitors
How XLY.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +14.9% is the highest of 4, against a peer median of -5.4%.
- Depreciation & amortization amounts to 7.5% of revenue for XLY.TO, versus a peer median of 22.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $21.99M USD | -0.8% | -13.6% | 39.4% | |
| LTM Mar 2026 | CA$18.1M CAD | -5.4% | -3.0% | 4.8% | |
| LTM Mar 2026 | CA$11.86M CAD | +14.9% | -17.2% | 7.5% | |
| LTM Mar 2026 | CA$103.71K CAD | -69.2% | -22.6% | — | |
| Peer median (excluding XLY.TO) | — | -5.4% | -13.6% | 22.1% | |
Competitors are the stored peer set for XLY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 83.83M | 94.47M | 101.08M | 122.33M | 151.48M |
| Cost of Revenue | 64.54M | 77.96M | 79.8M | 62.4M | 64.74M |
| Gross Profit | 19.29M | 16.51M | 21.28M | 59.93M | 86.74M |
| Gross Margin | 23.0% | 17.5% | 21.1% | 49.0% | 57.3% |
| Research & Development | 298K | 292K | 497K | 0 | 0 |
| Selling, General & Admin | 45.42M | 50.38M | 40.28M | 40.73M | 49.07M |
| Operating Expenses | 58.23M | 65.49M | 47.23M | 45.22M | 54.07M |
| Depreciation & Amortization | 14.27M | 20.18M | 11.21M | 10.28M | 11.45M |
| EBITDA | (18.3M) | (94.79M) | (10.89M) | 24.38M | 50.31M |
| EBITDA Margin | -21.8% | -100.3% | -10.8% | 19.9% | 33.2% |
| Operating Income | (38.94M) | (48.98M) | (25.95M) | 14.71M | 32.67M |
| Operating Margin | -46.4% | -51.8% | -25.7% | 12.0% | 21.6% |
| Interest Income | 1.59M | 337K | 32K | 240K | 130K |
| Interest Expense | 17.67M | 21.58M | 25.65M | 14.46M | 6.34M |
| Other Income / Expenses | (11.3M) | (87.58M) | (21.8M) | (15.07M) | (155K) |
| Income Before Tax | (50.24M) | (136.56M) | (47.75M) | (356K) | 32.52M |
| Pre-Tax Margin | -59.9% | -144.5% | -47.2% | -0.3% | 21.5% |
| Income Tax Expense | (4.33M) | (6.26M) | (3.24M) | 15.99M | (9.34M) |
| Net Income | (33.74M) | (130.29M) | (44.51M) | (16.35M) | 41.86M |
| Net Margin | -40.2% | -137.9% | -44.0% | -13.4% | 27.6% |
| EPS (Basic) | (0.06) | (0.15) | (0.04) | (0.01) | 0.03 |
| EPS (Diluted) | (0.06) | (0.15) | (0.04) | (0.01) | 0.03 |
| Weighted Avg Shares | 783.38M | 889.87M | 990.99M | 1.2B | 1.33B |
| Weighted Avg Shares (Diluted) | 783.38M | 889.87M | 990.99M | 1.2B | 1.59B |
Auxly Cannabis Group Inc.
TSX:XLY.TO
Intrinsic Alpha fair value
Locked
Current Price
$3.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.